120 related articles for article (PubMed ID: 33832119)
21. Clinical features of patients with carcinomatous meningitis in the Chinese population: report of 4 cases and review of the literature.
Duan H; Li M; Sun X
Turk Neurosurg; 2014; 24(1):13-8. PubMed ID: 24535785
[TBL] [Abstract][Full Text] [Related]
22. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid abnormalities in meningeosis neoplastica: a retrospective 12-year analysis.
Djukic M; Trimmel R; Nagel I; Spreer A; Lange P; Stadelmann C; Nau R
Fluids Barriers CNS; 2017 Mar; 14(1):7. PubMed ID: 28351400
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid tumor markers predict treatment response in a patient with carcinomatous meningitis.
Lin J; Wu S; Tian C; Shi Q
J Int Med Res; 2021 Jan; 49(1):300060520987946. PubMed ID: 33512249
[TBL] [Abstract][Full Text] [Related]
25. Keeping an open mind about meningitis: a case report of carcinomatous meningitis.
Walkty A; Abbott B; Swirsky N; Safneck J; Embil JM
CJEM; 2011 Sep; 13(5):352-6. PubMed ID: 21955418
[TBL] [Abstract][Full Text] [Related]
26. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
[TBL] [Abstract][Full Text] [Related]
27. Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis.
Viallon A; Desseigne N; Marjollet O; Birynczyk A; Belin M; Guyomarch S; Borg J; Pozetto B; Bertrand JC; Zeni F
Crit Care; 2011; 15(3):R136. PubMed ID: 21645387
[TBL] [Abstract][Full Text] [Related]
28. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
[TBL] [Abstract][Full Text] [Related]
29. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
30. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis.
Kang SJ; Kim KS; Ha YS; Huh SY; Lee JH; Kim JK; Kim MJ
J Clin Neurol; 2010 Mar; 6(1):33-7. PubMed ID: 20386641
[TBL] [Abstract][Full Text] [Related]
32. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
33. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis.
Subirá D; Simó M; Illán J; Serrano C; Castañón S; Gonzalo R; Granizo JJ; Martínez-García M; Navarro M; Pardo J; Bruna J
Clin Exp Metastasis; 2015 Apr; 32(4):383-91. PubMed ID: 25795393
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
Groves MD; Hess KR; Puduvalli VK; Colman H; Conrad CA; Gilbert MR; Weinberg J; Cristofanilli M; Yung WK; Liu TJ
J Neurooncol; 2009 Sep; 94(2):229-34. PubMed ID: 19267183
[TBL] [Abstract][Full Text] [Related]
39. [A case of meningeal melanomatosis diagnosed by immunostaining of cerebrospinal fluid].
Tamura Y; Umeda Y; Umeda M; Oyake M; Usuda H; Fujita N
Rinsho Shinkeigaku; 2020 Aug; 60(8):565-568. PubMed ID: 32641630
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer.
Lara-Medina F; Crismatt A; Villarreal-Garza C; Alvarado-Miranda A; Flores-Hernández L; González-Pinedo M; Gamboa-Vignolle C; Ruiz-González JD; Arrieta O
Breast J; 2012; 18(3):233-41. PubMed ID: 22487060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
